ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

• click to rate

  Posted by Two Blokes May 5 - Filed in Stock - 2 views
  
  ANIP's first-quarter 2025 revenues are likely to have been driven by increased sales of its lead product, Cortrophin Gel, and other rare disease products.